Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
Dec
4
2020
10:00—11:00 AM ET
November 23, 2020
Supply chain disruptions due to COVID-19 are twin threats, both to lives and livelihoods. We have focused some of our past discussions on COVID-19 and medical supply chains. Supply chain disruptions are also aggravating to the economic effects of the crisis. Companies must ensure the safety of worke...
Nov
12
2020
10:00—11:00 AM ET
November 04, 2020
Providing patients/end customers with high-quality medicines and health products in a timely and cost-effective manner requires well-functioning supply chains. Poor forecast accuracy impedes many improvement efforts for healthcare supply chain. More accurate demand forecasts using new predictive ana...
TESTIMONY
October 22, 2020
On Wednesday, September 23, CGD Senior Fellow Prashant Yadav appeared before the United States International Trade Commission (USITC) at a virtual hearing examining “COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges.” His testimony focused on trade and s...
Blog Post
October 14, 2020
To maximise the impact of this badly needed investment to combat COVID and, most importantly, to avoid any perverse and potentially catastrophic implications of World Bank financing undermining current global efforts led by Gavi and CEPI, we propose that the World Bank commit to the four principles ...